Genetic testing identifies inherited cancer mutations more effectively than a standard guideline-based approach, according to research published in JAMA Oncology.
The Latest
The U.S. Department of Defense Breast Cancer Research Program awarded Erik Nelson, PhD, the $4.5 million Era of Hope Scholar Award Oct. 30 to lead a research team that will study metastatic breast cancer treatment and prevention.
The Herbert Irving Comprehensive Cancer Center at Columbia University and NewYork-Presbyterian appointed Adam Bass, MD, founding director of the Center for Precision Cancer Medicine.
Since the July 2016 Medicaid expansion in Louisiana, there's been a 27 percent increase in early diagnosis of breast cancer, according to an upcoming study set for publication in Cancer.
Private equity buying sprees in radiation oncology along Florida's Paradise Coast have some physicians, researchers and antitrust regulators concerned, according to Bloomberg.
Cancer patients with COVID-19 have a 12.5 percent higher death risk compared to non-cancer patients with the illness, according to a study published today in Cancer.
Flash radiation therapy, also called Flash-RT, can eliminate the debilitating side effects associated with traditional radiation therapy by delivering the same dose in tenths of seconds, and can remove tumors, according to a study published in Clinical Cancer Research.
A national panel of health experts is for the first time recommending adults get screened for colon cancer at age 45 — five years earlier than current guidelines call for, reports NBC News.
Free breast and cervical cancer screenings are now available to uninsured and underinsured patients through New York City-based St. John's Episcopal Hospital's new cancer services program, according to a news release shared with Becker's.
The biomarker MiR130, a microRNA associated with ulcer-causing bacteria Helicobacter pylori can be detected through a blood test and may help identify early cases of gastric cancer, according to a study published in Gut.